Huang, Liu <br/><br/>
SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer.  [electronic resource] 

 -  PloS one  2013 
 - e77223 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0077223  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Camptothecin--analogs & derivatives<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>Haplotypes<br/>Humans<br/>Irinotecan<br/>Linkage Disequilibrium<br/>Liver-Specific Organic Anion Transporter 1<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Organic Anion Transporters--genetics<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide<br/>Prospective Studies<br/>Pyrimidines--chemistry<br/>Reduced Folate Carrier Protein--genetics<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult